Co-expression and predictive value of HER family members for the response to therapy with cetuximab in patients with metastatic colorectal cancer.

被引：0
|
作者：
Khelwatty, Said A. [1 ]
Puvanenthiran, Soozana [1 ]
Essapen, Sharadah [2 ]
Bagwan, Izhar [2 ]
Seddon, Alan M. [1 ]
Modjtahedi, Helmout [1 ]
机构：
[1] Kingston Univ London, Kingston Upon Thames, Surrey, England
[2] Royal Surrey Cty Hosp, Guildford, Surrey, England
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
350
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Consistent response to treatment with cetuximab monotherapy in patients with metastatic colorectal cancer.
    Lenz, HJ
    Mayer, RJ
    Mirtsching, B
    Cohn, AL
    Pippas, A
    Windt, P
    van Cutsem, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 255S - 255S
  • [2] Predictive biomarkers of response to cetuximab in Chinese patients with metastatic colorectal cancer
    Ma, Brigette
    Loong, Herbert
    Liem, Giok Siong
    Mo, Frankie
    Tong, Joanna
    Wong, S. C. Cesar
    Chan, Anthony T. C.
    To, Ka Fai
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer
    Khelwatty, Said A.
    Puvanenthiran, Soozana
    Essapen, Sharadah
    Bagwan, Izhar
    Seddon, Alan M.
    Modjtahedi, Helmout
    CANCERS, 2021, 13 (04) : 1 - 15
  • [4] Co-expression and prognostic significance of HER family members and EGFRvIII in patients with hepatocellular carcinoma
    Sherif, Ozlem
    Khelwatty, Said
    Bagwan, Izhar
    Seddon, Alan
    Dalgleish, Angus
    Mudan, Satvinder
    Modjtahedi, Helmout
    CANCER RESEARCH, 2024, 84 (06)
  • [5] The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer
    Khelwatty, Said
    Essapen, Sharadah
    Bagwan, Izhar
    Green, Margaret
    Seddon, Alan
    Modjtahedi, Helmout
    ONCOTARGET, 2017, 8 (05) : 7666 - 7677
  • [6] Predictive value of wild-type EGFR determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer
    Khelwatty, Said Abdullah
    Essapen, Sharadah
    Bagwan, Lzhar
    Green, Margaret
    Seddon, Alan
    Modjtahedi, Helmout
    CANCER RESEARCH, 2016, 76
  • [7] Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer
    Sawada, Kentaro
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Kuboki, Yasutoshi
    Yamaguchi, Daisuke
    Yuki, Satoshi
    Yoshino, Takayuki
    Komatsu, Yoshito
    Sakamoto, Naoya
    Okamoto, Wataru
    Fujii, Satoshi
    CLINICAL COLORECTAL CANCER, 2018, 17 (03) : 198 - 205
  • [8] Co-Expression of HER Family Members in Patients with Dukes' C and D Colon Cancer and Their Impacts on Patient Prognosis and Survival
    Khelwatty, Said Abdullah
    Essapen, Sharadah
    Bagwan, Izhar
    Green, Margaret
    Seddon, Alan Michael
    Modjtahedi, Helmout
    PLOS ONE, 2014, 9 (03):
  • [9] Perioperative therapy in patients with metastatic colorectal cancer.
    Alese, Olatunji B.
    Zakka, Katerina Mary
    Huo, Xingyue
    Jiang, Renjian
    Shaib, Walid Labib
    Wu, Christina
    Akce, Mehmet
    Sullivan, Patrick S.
    Behera, Madhusmita
    El-Rayes, Bassel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Co-Expression of HER Family Relates to Progression and Lymph Node Metastases in Human Colorectal Cancer
    Nozaka, Hiroyuki
    Igarashi, Ai
    Togashi, Miku
    Kurosawa, Sayaka
    Takahashi, Yayoi
    Uesugi, Noriyuki
    Ishida, Kazuyuki
    Sugai, Tamotsu
    LABORATORY INVESTIGATION, 2017, 97 : 191A - 191A
12345